Manual IP - our flagship publication contains 238 jurisdictions covering patents, trademarks, utility models and designs for Pharma specialists. Extract the following information to assist in the prosecution of your IP rights:
|
|
Kluwer IP Law has an impressive collection on new perspectives and innovations in the pharmaceutical sector
Guide to EU Pharmaceutical Regulatory Law
A comprehensive and practical guide to, and analysis of, the current European Union (EU) Pharmaceutical Regulatory Regime.
Patent Protection for Second Medical Uses
This detailed country-by-country analysis shows how jurisdictions vary significantly in treatment of claims of ‘second medical use’.
TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil
Although ideally, a patent system for pharmaceuticals should serve to incentivise research into the development of new medicines, the COVID-19 pandemic has exposed the equal importance of drug access and affordability.
Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law
A critical analysis that examines patent settlements between originators and generic pharmaceutical manufacturers under United States antitrust and European Union competition law.
Stay up to date on IP case law and other developments from the pharmaceutical sector.
Kluwer IP Law publishes widely on a variety of issues that will assist pharmaceutical patent practitioners:
- Find pharma litigation cases that help protect the most valuable resource for companies worldwide
- Read the latest peer-reviewed articles on pharma written by professionals from the industry
- Pharma blog posts on IP Law by experts covering the latest cases and recent developments
If you would like to learn more about our Kluwer IP Law database or if you have any questions, please contact us: